| Literature DB >> 31460591 |
Cláudia Alves Couto1, Debora Raquel Benedita Terrabuio2, Eduardo Luiz Rachid Cançado2, Gilda Porta3, Cynthia Levy4, Antônio Eduardo Benedito Silva5, Paulo Lisboa Bittencourt6, Roberto José de Carvalho Filho5, Dalton Marques Chaves2, Irene Kazue Miura3, Liana Codes6, Luciana Costa Faria1, Andreia Silva Evangelista7, Alberto Queiroz Farias2, Luciana Lofêgo Gonçalves8, Michelle Harriz2, Edmundo Pessoa de Almeida Lopes9, Gustavo Oliveira Luz2, Patrícia Marinho Costa Oliveira2, Elze Maria Gomes Oliveira5, Janaina Luz Narciso Schiavon10, Tiago Sevá-Pereira11.
Abstract
New data concerning the management of autoimmune liver diseases have emerged since the last single-topic meeting sponsored by the Brazilian Society of Hepatology to draw recommendations about the diagnosis and treatment of autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), overlap syndromes of AIH, PBC and PSC and specific complications and topics concerning AIH and cholestatic liver diseases. This manuscript updates those previous recommendations according to the best evidence available in the literature up to now. The same panel of experts that took part in the first consensus document reviewed all recommendations, which were subsequently scrutinized by all members of the Brazilian Society of Hepatology using a web-based approach. The new recommendations are presented herein.Entities:
Mesh：
Year: 2019 PMID： 31460591 DOI： 10.1590/S0004-2803.201900000-43
Source DB: PubMed Journal: Arq Gastroenterol ISSN： 0004-2803